Prognostic value of post surgery liquid biopsy cell free circulating tumor DNA in stage III colon cancer patients PLCRC PROVENC3 study

Carmen Rubio Alarcón (1), Steven L.C. Ketelaars (1), Ingrid A. Franken (2), Sietske C. van Nassau (2), Dave E.W. van der Kruijssen (2), Suzanna J. Schraa (2), Theodora C. Linders (3), Pien Delis-van Diemen (1), Maartje Alkemade (4), Anne Bolijn (1), Marianne Tijssen (1), Margriet Lemmens (1), Miranda van Dongen (1), Mirthe Lanfermeijer (1), Annegien Broeks (4), Lana Meiqari (1), Linda J.W. Bosch (1), Victor E. Velculescu (6), Amy Greer (5), Samuel V. Angiuoli (5), Andrew Georgiadis (5), David Riley (5), James R. White (5), Christopher Greco (5), Liam Cox (5), Daan van den Broek (3), Cornelis J.A. Punt (7), Veerle M.H. Coupé (8), Miriam Koopman (2), Jeanine Roodhart (2), Gerrit A. Meijer (1), Mark Sausen (5), Geraldine R. Vink (2,9), Remond J.A. Fijneman (1)

1 The Netherlands Cancer Institute, Dept of Pathology, Amsterdam, The Netherlands . 2 Department of medical oncology, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands. 3 The Netherlands Cancer Institute, Dept of Laboratory Medicine, Amsterdam, The Netherlands. 4 CFMPB, The
Netherlands Cancer institute, Amsterdam, The Netherlands. 5 Personal Genome Diagnostics ( Labcorp ), Baltimore, MD , USA. 6 Johns Hopkins University School of Medicine, Baltimore, MD , USA. 7 Julius Centre, University Medical Centre, Utrecht, The Netherlands. 8 Amsterdam University Medical Centres , Location VU
medical center, Department of Epidemiology and Biostatistics, Amsterdam, The Netherlands. 9 Department of Research and Development, Netherlands Comprehensive Cancer Organisation , Utrecht, The Netherlands